Moderna
MRNA
#1232
Rank
HK$114.56 B
Marketcap
HK$297.70
Share price
3.55%
Change (1 day)
-50.49%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Cash on Hand

Cash on Hand as of September 2024 : HK$53.44 Billion

According to Moderna 's latest financial reports the company has HK$53.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Moderna - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$67.19 B-13.14%
2022-12-31HK$77.36 B-7.51%
2021-12-31HK$83.64 B134.15%
2020-12-31HK$35.72 B315.84%
2019-12-31HK$8.59 B-27.9%
2018-12-31HK$11.91 B101.7%
2017-12-31HK$5.90 B-28.01%
2016-12-31HK$8.20 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$0.73 B-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$113.57 B 112.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.93 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$21.63 B-59.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.11 B 104.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$3.38 B-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$157.97 B 195.57%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA